• Non ci sono risultati.

Hypomelanosis of Ito

N/A
N/A
Protected

Academic year: 2022

Condividi "Hypomelanosis of Ito"

Copied!
4
0
0

Testo completo

(1)

528 528 In 1952, Ito reported a female patient with a widespread, symmetric pattern of depigmented whorls and streaks, naming it incontinentia pigmenti achromians, because the distribution of the depigmented lesions is the negative image of the hyper- pigmented streaks of incontinentia pigment. Hypomelanosis of Ito (HI) is a relatively common disorder with a frequency of 1 in 8000–10,000 patients in a general pediatric hospital and 1 in 1000 patients in a pediatric neurology service.

GENETICS/BASIC DEFECTS

1. Inheritance

a. Sporadic occurrence in nearly all cases with no affected sibs or parents

i. Result of a de novo postzygotic mutation ii. Mutation can only survive in a mosaic state b. Only a few cases with possible genetic inheritance

reported

i. X-linked dominant inheritance ii. Autosomal dominant

iii. Autosomal recessive 2. Pathogenesis

a. Chromosome abnormalities (52%)

i. Mosaicism leading to generation of two cell lin- eages producing patterns of hypopigmented and hyperpigmented skin

ii. Balanced X/autosome translocations

iii. Supernumerary X chromosome/ring fragment iv. Ring chromosomes (10, 14, 22)

v. Mosaic triploidy

vi. Mosaic trisomies (8, 13, 14, 18, 22) vii. Mosaic translocations

viii. Mosaic deletions

ix. Autosomal deletions and duplications involving chromosomes 7, 12, 13, 14, 15, and 18

b. X chromosome abnormalities i. Inactivation

ii. Activation iii. Mosaicism

3. A descriptive term rather than a true syndrome

a. Suggested by the pattern of chromosomal aberrations and the polymorphic nature of the disease

b. A term used for a phenotype

i. Presence of linear streaks lighter than the patient’s background skin color, extending around the trunk and down the long axes of the extremities, roughly following the lines of Blaschko

ii. Association with systemic findings

CLINICAL FEATURES

1. Cutaneous symptoms a. Onset

i. Recognizable at birth (54%) ii. Visible during childhood (70%)

b. No signs of inflammation or verrucous changes char- acteristically seen in incontinentia pigmenti

c. Hypopigmented lesions i. Typical phenotype

a) Cutaneous pattern: essentially the reverse of the third stage of incontinentia pigmenti b) Bilateral or unilateral whirls, patches, and

streaks corresponding to the lines of Blaschko, often showing a midline cutoff

c) Eruption not preceded by any inflammatory lesions (unlike incontinentia pigmenti) ii. Unilateral skin lesions contralateral to the side of

brain malformation in patients with HI and hemimegalencephaly

iii. Wood lamp useful in demonstrating hypopig- mented lesions in persons with fair skin

iv. Atypical phenotype: checkerboard pattern, zos- teriform, dermatomal, or plaquelike arrangement d. Nonspecific skin lesions (20–40%)

i. Café-au-lait spots

ii. Persistent mongolian blue spots iii. Nevus of Ota

iv. Nevus marmoratus and angiomatous nevi v. Soft fibroma

vi. Pilomatrixoma vii. Aplasia cutis viii. Atopic dermatitis 2. Hair/nail/sweat gland anomalies

a. Focal hypertrichosis b. Slow growth c. Diffuse alopecia d. Coarse, curly hair e. Trichorrhexis

f. Widows peak

g. Generalized hirsutism h. Facial hypertrichosis

i. Low hairline j. Ungual hypoplasia

k. Hypohidrosis corresponding to hypopigmented areas 3. Associated extracutaneous anomalies (75%)

a. CNS anomalies

i. Mental retardation (50–75%) ii. Seizures (50%)

iii. Autistic behavior (11%) iv. Microcephaly

v. Hypotonia vi. Hyperkinesia vii. Ataxia viii. Deafness

ix. Hemimegalencephaly

Hypomelanosis of Ito

(2)

HYPOMELANOSIS OF ITO 529

x. Brain tumors (medulloblastoma, choroid plexus papilloma)

b. Ophthalmological abnormalities (20%) i. Microphthalmia

ii. Ptosis

iii. Nonclosure of the upper lid iv. Symblepharon

v. Dacryostenosis vi. Strabismus vii. Nystagmus viii. Myopia

ix. Hyperopia x. Astigmatism xi. Amblyopia xii. Megalocornea xiii. Corneal opacification

xiv. Cataracts

xv. Iridal heterochromia xvi. Scleral melanosis xvii. Heterochromia of the iris xviii. Optic atrophy

xix. Striated patchy hypopigmented fundi xx. Retinal detachment

c. Dental abnormalities

i. Defective dental implantation ii. Conical teeth

iii. Partial anodontia

iv. Dental dysplasia/hypoplasia v. Defective enamel

vi. Hamartomatous dental cusps d. Skeletal defects

i. Short stature

ii. Facial and limb asymmetry (hemihypertrophy) iii. Pectus carinatum or excavatum

iv. Scoliosis v. Syndactyly vi. Polydactyly vii. Brachydactyly viii. Clinodactyly e. Congenital heart defect

i. Tetralogy of Fallot ii. Pulmonary stenosis iii. Ventricular septal defect

iv. Atrial septal defect

v. Incomplete right bundle branch block vi. Cardiomegaly of unknown etiology f. Abdomen/gastrointestinal anomalies

i. Diastasis recti ii. Hepatomegaly

iii. Segmental dilation of the colon

iv. Diaphragmatic, umbilical, and inguinal hernias g. Genitourinary anomalies

i. Hypospadias ii. Micropenis iii. Single kidney

iv. Urethral duplication v. Cryptorchidism vi. Precocious puberty vii. Gynecomastia viii. Asymmetrical breasts

ix. Nephritis

4. Diagnostic criteria (Ruiz-Maldonado et al., 1992) a. Sine qua non criterion: congenital or early acquired

nonhereditary cutaneous hypopigmentation in linear streaks or patches involving more than two body segments

b. Major criterion

i. One or more nervous system anomalies ii. One or more musculoskeletal anomalies c. Minor criterion

i. Two or more congenital malformations other than nervous system or musculoskeletal anomalies ii. Chromosomal anomalies

d. Definitive diagnosis: sine qua non criterion plus one or more major criteria or two or more minor criteria e. Presumptive diagnosis: sine qua non criterion alone

or in association with one minor criterion

DIAGNOSTIC INVESTIGATIONS

1. Cytogenetic investigation

a. Peripheral blood karyotyping indicated especially when systemic manifestations are present

b. Fibroblast karyotyping by sampling the dark and light skin for demonstrating mosaicism or chromosomal abnormalities

c. Presence of a wide variety of karyotypic abnormalities 2. Histopathology

a. Decreased numbers of melanocytes

b. Decreased numbers and size of pigmented melanosomes c. Neuropathological features

i. Polymicrogyria

ii. Disarray of cortical lamination

iii. Heterotopic neurons in the white matter iv. Giant cells

3. CT and MRI of the brain

a. White matter abnormalities somewhat predictive of a poor neurological outcome

b. Neuroblast migration i. Heterotopia ii. Pachygyria iii. Polymicrogyria

c. Localized or generalized cerebral atrophy d. Cerebral hemiatrophy

e. Hemimegalencephaly f. Other rare anomalies

i. Noncommunicating hydrocephalus ii. Megacisterna magna

iii. Arteriovenous malformation

iv. Cerebellar hypoplasia (hemispheres and vermis) v. Brainstem hypoplasia

vi. Brain tumors

4. Radiography for musculoskeletal anomalies 5. EEG for seizures

GENETIC COUNSELING

1. Recurrence risk

a. Patient’s sib: not increased unless a parent shows chromosomal abnormalities

b. Patient’s offspring:

i. Not increased unless the patient has chromosomal abnormalities

(3)

530 HYPOMELANOSIS OF ITO

ii. Guarded counseling in women with a phenotype similar to HI who have nonmosaic balanced X;

autosome translocations

2. Prenatal diagnosis: undetermined for affected mother who has a specific type of chromosome abnormality 3. Management

a. Early intervention programs including physical, occu- pational, and speech therapies

b. Special education c. Seizure control

d. Surgical treatment of cataracts and retinal detachment

REFERENCES

De Menezes MS: Hypomelanosis of Ito. EMedicine, 2002. http://www.

emedicine.com

Flannery DB: Pigmentary dysplasias, hypomelanosis of Ito, and genetic mosaicism. Am J Med Genet 35:18–21, 1990.

Fryburg JS, Lin KY, Matsumoto J: Abnormal head MRI in a neurologically normal boy with hypomelanosis of Ito. Am J Med Genet 66:200–203, 1996.

Glover MT, Brett EM, Atherton DJ: Hypomelanosis of Ito: spectrum of the dis- ease. J Pediatr 115:75–80, 1989.

Gordon N: Hypomelanosis of Ito (incontinentia pigmenti achromians). Dev Med Child Neurol 36:271–274, 1994.

Happle R: Mosaicism in human skin: understanding the patterns and mecha- nisms. Arch Dermatol 129:1460–1470, 1993.

Happle R: Pigmentary patterns associated with human mosaicism: a proposed classification. Eur J Dermatol 3:170–184, 1993.

Harre J, Millikan LE: linear and whorled pigmentation. Int J Dermatol 33:529–537, 1994.

Hatchwell E, Robinson D, Crolla JA, et al.: X inactivation analysis in a female with hypomelanosis of Ito associated with a balanced X;17 transloca- tion: evidence for functional disomy of Xp. J Med Genet 33:216–220, 1996.

Ishikawa T, Kanayama M, Sugiyama K, et al.: Hypomelanosis of Ito associated with benign tumors and chromosomal abnormalities: a neurocutaneous syndrome. Brain Dev 7:45–49, 1985.

Ito M: A singular case of naevus depigmentosus systematicus bilateralis. Jpn J Dermatol 61:31–32, 1951.

Koiffmann CP, de Souza DH, Diament A, et al.: Incontinentia pigmenti achro- mians (hypomelanosis of Ito, MIM 146150): Further evidence of Localization at Xp11. Am J Med Genet 46:529–533, 1993.

Küster W, Konig A: Hypomelanosis of Ito: no entity, but a cutaneous sign of mosaicism. Am J Med Genet 85:346–350, 1999.

Metzker A, Morag C, Weitz R: Segmental pigmentation disorder. Acta Derm Venereol (Stockh) 63:167–169, 1982.

Moss C ,Burn J: Genetic counselling in hypomelanosis of Ito: case report and review. Clin Genet 34:109–115, 1988.

Nehal KS, PeBenito R, Orlow SJ: Analysis of 54 cases of hypopigmentation and hyperpigmentation along the lines of Blaschko. Arch Dermatol 132:1167–1170, 1996.

Ohashi H, Tsukahara M, Murano I, et al.: Pigmentary dysplasias and chromo- somal mosaicism: report of 9 cases. Am J Med Genet 43:716–721, 1992.

Ono J, Harada K, Kodaka R, et al.: Regional cortical dysplasia associated with suspected hypomelanosis of Ito. Pediatr Neurol 17:252–254, 1997.

Pascual-Castroviejo I, Lopez-Rodriguez L, de la Cruz Medina M, et al.:

Hypomelanosis of Ito. Neurological complications in 34 cases. Can J Neurol Sci 15:124–129, 1988.

Pascual-Castroviejo I, Roche C, Martinez-Bermejo A, et al.: Hypomelanosis of ITO. A study of 76 infantile cases. Brain Dev 20:36–43, 1998.

Ritter CL, Steele MW, Wenger SL, et al.: Chromosome mosaicism in hypome- lanosis of Ito. Am J Med Genet 35:14–17, 1990.

Ross DL, Liwnicz BH, Chun RW, Gilbert E: Hypomelanosis of Ito (incontinen- tia pigmenti achromians)—a clinicopathologic study: macrocephaly and gray matter heterotopias. Neurology 32:1013–1016, 1982.

Rott H-D, Lang GE, Huk LW, et al.: Hypomelanosis of Ito (incontinentia pig- menti achromians). Ophthalmological evidence for somatic mosaicism.

Ophthalmic Paediatr Genet 11:273–279, 1990.

Rubin MB: Incontinentia pigmenti achromians. Multiple cases within a family.

Arch Dermatol 105:424–425, 1972.

Ruggieri M, Tigano G, Mazzone D, et al.: Involvement of the white matter in hypomelanosis of Ito (incontinentia pigmenti achromians). Neurology 46:485–492, 1996.

Ruggieri M: Familial hypomelanosis of Ito: implications for genetic coun- selling. Am J Med Genet 95:82–84, 2000.

Ruggieri M, Pavone L: Hypomelanosis of Ito: clinical syndrome or just pheno- type? J Child Neurol 15:635–644, 2000.

Ruiz-Maldonado R, Toussaint S, Tamayo L, et al.: Hypomelanosis of Ito: diag- nostic criteria and report of 41 cases. Pediatr Dermatol 9:1–10, 1992.

Steiner J, Adamsbaum C, Desguerres I, et al.: Hypomelanosis of Ito and brain abnormalities: MRI findings and literature review. Pediatr Radiol 26:763–768, 1996.

Sybert VP, Pagon RA, Donlan M, Bradley CM: Pigmentary abnormalities and mosaicism for chromosomal aberration: association with clinical features similar to hypomelanosis of Ito. J Pediatr 116:581–586, 1990.

Sybert VP, Pagon RA: Hypomelanosis of Ito in a girl with plexus papilloma and translocation (X;17) [letter]. Hum Genet 93:227, 1994.

Sybert VP: Hypomelanosis of Ito: a description, not a diagnosis. J Invest Dermatol 103(5 Suppl):141S–143S, 1994.

Tagawa T, Futagi Y, Arai H: Hypomelanosis of Ito associated with hemimega- lencephaly: a clinicopathological study. Pediatr Neurol 17:180–184, 1997.

Urgelles E, Pascual-Castroviejo I, Roche C, et al.: Arteriovenous malformation in hypomelanosis of Ito. Brain Dev 18:78–80, 1996.

Weaver RG Jr, Martin T, Zanolli MD: The ocular changes of incontinentia pig- menti achromians (hypomelanosis of Ito). J Pediatr Ophthalmol Strabismus 28:160–163, 1991.

Zajac V, Kirchhoff T, Levy ER, et al.: Characterisation of X;17(q12;p13) translocation breakpoints in a female patient with hypomelanosis of Ito and choroid plexus papilloma. Eur J Hum Genet 5:61–8, 1997.

(4)

HYPOMELANOSIS OF ITO 531

Fig. 1. Two children with hypomelanosis of Ito showing hypopigmented skin lesions in a characteristic distribution of whirls and streaks on the trunk and limbs. The first patient has 49,XXXXY.

Riferimenti

Documenti correlati

In order to apply the proposed architecture to a different context of use, the main effort would be: (i) locating and formalizing with Alium a guideline about patients with a disease

I4 agosto 1996, n. 494, proposte di modificazioni o integrazioni al piano di sicurezza e di coordinamento loro trasmesso dalla stazione appaltante, sia per

White matter abnormalities with enlarged perivascular spaces are more common- ly seen in patients with a mental handicap, although they have also been observed in HMI patients with

The lesions usual- ly involve both cortex and white matter of the cerebral hemispheres, but the most severe lesions are usually seen in the deep white matter. The lesions may also

VISTA l’ordinanza del Ministro della salute 20 marzo 2020, recante “Ulteriori misure urgenti in materia di contenimento e gestione dell’emergenza epidemiologica da COVID-19,

However, if available, information on invertebrate non-target organisms (e.g. endocrine mechanistic and/or adverse effect data) should be considered in the assessment applying

Specifically, our results suggest that the learning abilities most affected are arithmetic reasoning and reading skills, which are reported here for the first time as specific

Kenwrick S, The International IP Consortium: Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or